Top Page
Denka Co
(4061)
Denka Co (4061) vs. iShares MSCI Japan ETF (EWJ)
Denka Co Business Overview & Revenue Model
Denka Co Financial Statement Overview
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 399.09B | 400.25B | 389.26B | 407.56B | 384.85B | 354.39B |
| Gross Profit | 82.56B | 84.59B | 82.50B | 102.34B | 107.17B | 100.19B |
| EBITDA | 45.68B | 12.87B | 43.09B | 42.79B | 59.44B | 52.78B |
| Net Income | -9.55B | -12.30B | 11.95B | 12.77B | 26.01B | 22.79B |
Balance Sheet | ||||||
| Total Assets | 650.89B | 655.52B | 616.24B | 592.15B | 557.64B | 526.03B |
| Cash, Cash Equivalents and Short-Term Investments | 42.55B | 37.00B | 35.39B | 20.20B | 20.21B | 25.91B |
| Total Debt | 222.64B | 217.68B | 174.37B | 169.73B | 137.03B | 138.19B |
| Total Liabilities | 339.72B | 347.22B | 299.33B | 291.80B | 265.55B | 255.99B |
| Stockholders Equity | 293.44B | 296.18B | 307.54B | 296.48B | 288.47B | 267.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -41.21B | -8.42B | -30.89B | 4.68B | 3.12B |
| Operating Cash Flow | 0.00 | 18.62B | 36.26B | 8.95B | 42.63B | 40.61B |
| Investing Cash Flow | 0.00 | -59.59B | -22.57B | -28.27B | -36.84B | -36.98B |
| Financing Cash Flow | 0.00 | 40.12B | 712.00M | 18.36B | -12.34B | -6.71B |
Denka Co Technical Analysis
Denka Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥12.17T | 24.10 | 10.87% | 2.17% | 3.77% | 0.35% | |
69 Neutral | ¥379.32B | 21.49 | ― | 5.28% | -0.47% | 25.41% | |
68 Neutral | ¥868.55B | 25.35 | 4.79% | 4.21% | -1.21% | -27.21% | |
66 Neutral | ¥1.54T | 17.55 | 1.09% | 3.50% | -11.50% | 25.86% | |
65 Neutral | ¥932.85B | 9.58 | 8.79% | 2.68% | -1.64% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥317.04B | -33.94 | -4.00% | 3.71% | 0.24% | -234.36% |
Denka Co Corporate Events
Denka has begun formally reviewing a potential spin-off of its styrene-related businesses within the Polymer Solutions Division, targeting completion around April 2027, as part of its Mission 2030 portfolio transformation. The move reflects mounting pressures from global overcapacity, weaker pricing power, rising carbon-cost burdens, and high fixed costs that have undermined profitability in this capital-intensive segment.
By separating the styrene operations, Denka aims to give the unit greater independence, improve agility in decision-making, strengthen its earnings structure, and open the door to strategic options such as industry collaboration and capital alliances. Management stresses the review is a proactive step to enhance business value rather than a mere downsizing, with the ultimate goal of securing sustainable competitiveness and enabling future growth investments in the spun-off entity.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3565.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka has updated its Mission 2030 management plan with a Phase 2 program covering fiscal years 2026 to 2028, following an expected recovery to ¥25 billion in operating income and at least 5% ROE in fiscal 2025. The revised plan targets rebuilding earning power, aiming for record operating income and an 8% ROE by strengthening ICT and energy and healthcare businesses, reshaping sustainable living into cash-generative operations, resolving the DPE issue while limiting financial damage, and tightly selecting investments to restore its balance sheet.
Management also plans to expand existing businesses through 2030 under a so-called Trickle Out Strategy while planting seeds for at least 10 new initiatives for the period beyond 2030. By pursuing a growth model that balances differently paced ICT, energy, and healthcare segments, Denka aims to secure sustainable, distinctive growth and reinforce its role in providing solutions to social issues, signaling to stakeholders a shift into a new growth stage under a stronger execution-focused regime.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3565.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka has launched Phase 2 of its “Mission 2030” management plan for fiscal years 2026 to 2028, after Phase 1 was hit by slumping demand for electronic materials, weak U.S. chloroprene rubber performance and slower-than-expected payback on EV-related investments, which, alongside higher fixed costs, eroded profitability. The new phase is framed as a rebuilding period focused on restoring earnings power to achieve record operating income and an 8% ROE, while tightening financial discipline, recasting business units as growth drivers, stable earners or cash cows, and prioritizing strategic expansion, capital efficiency and returns on past investments to underpin a future portfolio centered on ICT & Energy and Healthcare, with Sustainable Living reshaped around “winning” cash-generative businesses.
Non-financial targets remain central to Mission 2030, with Denka working toward deep cuts in greenhouse gas emissions from its 2013 baseline, maintaining the build-out of renewable energy capacity and improving workplace safety metrics. The company is also targeting a sharp increase in the share of female managers by 2030, signalling that governance and human capital development are being tied directly to its efforts to reinforce competitiveness and secure sustainable, long-term growth across its chosen megatrend-linked markets.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3565.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka has set up a wholly owned subsidiary, Flowers Co., Ltd., to launch a tender offer for all common shares of KAINOS Laboratories, Inc., which is listed on the Tokyo Stock Exchange’s Standard Market. The vehicle was established in January 2026 to own KAINOS shares and manage its operations, with Denka executive officer Taro Inada serving as representative director.
To finance the transaction, Denka plans to subscribe for common shares in Flowers while Development Bank of Japan will subscribe for non-voting class A shares carrying preferred dividends and a call option. Denka and DBJ intend to conclude an investment agreement and a shareholders’ pact governing the target’s operations and Flowers’ shareholding structure, underscoring a joint investment framework aimed at taking full control of KAINOS through the tender offer.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3332.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka Company Limited will book an extraordinary loss of ¥14.2 billion for the first nine months of the fiscal year ending March 2026, stemming from the liquidation of business at its U.S. subsidiary Denka Performance Elastomer LLC, which has decided not to restart production at its chloroprene rubber facilities for an indefinite period. The loss, largely related to write-downs of raw materials, intermediate goods and associated labor and removal costs, is expected to be offset by extraordinary gains from asset sales and other factors, and is already incorporated into Denka’s full-year consolidated earnings forecast, limiting the immediate impact on its overall financial outlook.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3257.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka Company Limited has announced a reshuffle of its executive officer lineup effective April 1, 2026, following a resolution by its Board of Directors. While President and CEO Ikuo Ishida, CFO and CSCO Rimiru Hayashida, and several other senior executives retain their current roles, the company is adjusting responsibilities across key operational areas and promoting Omi Plant head Michio Kawamura to Managing Executive Officer, signaling a reinforcement of its manufacturing and safety leadership. Executive responsibilities are being realigned in technology, production engineering, sustainability promotion, digital strategy, plant management, and new business development, reflecting Denka’s focus on strengthening governance, operational efficiency, and innovation across its production sites and business divisions.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3257.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka reported on the ongoing suspension of production at Denka Performance Elastomer LLC, its U.S. chloroprene rubber manufacturing subsidiary, detailing the systematic shutdown of facilities and related cost-control measures. The company has completed removal of high-priority materials based on safety assessments, is steadily cleaning equipment and clearing remaining raw materials and intermediates, and is significantly reducing the subsidiary’s workforce from about 250 employees in March 2025 to an anticipated 100 by April 2026, while continuing discussions with relevant stakeholders to minimize future costs and manage the operational and financial impact of the shutdown.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3257.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.
Denka reported consolidated net sales of ¥290.8 billion for the first nine months of the fiscal year ending March 31, 2026, a 3.6% year-on-year decline, but significantly improved profitability, with operating income up 54.0% to ¥18.2 billion and net income attributable to owners of the parent more than doubling to ¥5.5 billion. The company maintained a solid financial position with total assets of about ¥655.2 billion and an unchanged equity ratio of 45.2%, kept its interim dividend at ¥50 per share, and reaffirmed a full-year dividend forecast of ¥100 per share, while revising its earnings outlook upward to project sharply higher full-year operating and ordinary income despite slightly lower sales, signaling a stronger profit structure and improved earnings efficiency for shareholders and investors.
The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3257.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.